Neutral and Anionic Liposome-Encapsulated Hemoglobin: Effect of Postinserted Poly(ethylene glycol)-distearoylphosphatidylethanolamine on Distribution and Circulation Kinetics

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 1, 2004, Pages 241-248

  Awasthi, V D ^a   Garcia, D ^a   Klipper, R ^a   Goins, B A ^a   Phillips, W T ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DISTEAROYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLETHANOLAMINE; GLYCEROPHOSPHOLIPID; HEMOGLOBIN; LIPID; LIPOSOME; MACROGOL; OXYGEN; PHOSPHOLIPID; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BLOOD SAMPLING; CIRCULATION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG LIVER LEVEL; DRUG UPTAKE; ENCAPSULATION; HUMAN; ISOTOPE LABELING; LIPID COMPOSITION; LIPID VESICLE; LOW DRUG DOSE; MALE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RABBIT; RADIOACTIVITY; RETICULOENDOTHELIAL SYSTEM; SCINTILLATION CAMERA; SURFACE CHARGE;

ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HEMOGLOBINS; KINETICS; LIPOSOMES; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; RABBITS; TISSUE DISTRIBUTION;

EID: 1642346631     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.060228     Document Type: Article

References (40)

1. Ahl PL, Bhatia SK, Meers P, Roberts P, Stevens R, Dause R, Perkins WR, and Janoff AS (1997) Enhancement of the in vivo circulation lifetime of L-a-distearoylphosphatidylcholine liposomes: importance of liposomal aggregation versus complement opsonization. Biochim Biophys Acta 1329:370-382.
2. Allen T and Hansen C (1991) Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim Biophys Acta 1068:122-141.
3. Allen TM, Hansen C, and Rutledge J (1989) Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochim Biophys Acta 981:27-35.
4. Awasthi VD, Garcia D, Goins BA, and Phillips WT (2003) Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits. Int J Pharm 253:121-132.
5. Devine DV and Bradley AJ (1998) The complement system in liposome clearance: can complement deposition be inhibited. Adv Drug Delivery Rev 32:19-29.
6. Drummond DC, Meyer O, Hong K, Kirpotin DB, and Papahadjoulos D (1999) Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 51:691-743.
7. Gabizon A and Papahadjoulos D (1992) The role of surface charge and hydrophilic groups on liposome clearance in vivo. Biochim Biophys Acta 1103:94-100.
8. Goins B, Phillips WT, and Klipper R (1996) Blood-pool imaging using technetium-99m-labeled liposomes. J Nucl Med 37:1374-1379.
9. Gregoriadis G (1995) Fate of liposomes in vivo and its control: a historical perspective, in Stealth Liposomes (Martin F ed) pp 7-12, CRC Press, Boca Raton, FL.
10. Harashima H, Matsuo H, and Kiwada H (1998) Identification of proteins mediating clearance of liposomes using a liver perfusion system. Adv Drug Delivery Rev 32:61-79.
11. Klibanov AL, Maruyama K, Bekerleg AM, Torchilin VP, and Huang L (1991) Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim Biophys Acta 1062:142-148.
12. Lasic DD and Martin F (eds) (1995) Stealth Liposomes. CRC Press, Boca Raton, FL.
13. Laverman P, Brouwers AH, Dams ETM, Oyen WJG, Storm G, Rooijen NV, Corstens FHM, and Boerman OC (2000) Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose. J Pharmacol Exp Ther 293:996-1001.
14. Litzinger DC and Huang L (1992) Amphipathic ploy(ethyelne glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen. Biochim Biophys Acta 1127:249-254.
15. Liu D, Mori A, and Huang L (1992) Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. Biochim Biophys Acta 1104:95-101.
16. Maruyama K, Yuda T, Okamoto A, Kojima S, Suginaka A, and Iwatsuru M (1992) Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim Biophys Acta 1128:44-49.
17. Matsuoka T (1997) Determination of methemoglobin and carboxyhemoglobin in blood by rapid colorimetry. Biol Pharm Bull 20:1208-1211.
18. Miller CR, Bondurant B, McLean SD, McGovern KA, and O'Brien DF (1998) Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes. Biochemistry 37:12875-12883.
19. Nicholas AR, Scott MJ, Kennedy NI, and Jones MN (2000) Effect of grafted polyethylene glycol (PEG) on the size, encapsulation efficiency and permeability of vesicles. Biochim Biophys Acta 1463:167-178.
20. Oja CD, Semple SC, Chonn A, and Cullis PR (1996) Influence of dose on liposome clearance: critical role of blood proteins. Biochim Biophys Acta 1281:31-37.
21. Phillips W, Klipper R, Awasthi V, Rudolph A, Cliff R, Kwasiborski V, and Goins B (1999) Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute. J Pharmacol Exp Ther 288:665-670.
22. Phillips WT (1999) Delivery of gamma-imaging agents by liposomes. Adv Drug Delivery Rev 37:13-32.
23. Phillips WT, Rudolph AS, Goins B, Timmons JH, Klipper R, and Blumhardt R (1992) A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. Nucleic Med Biol 19:539-547.
24. Reiss JG (2001) Oxygen carriers ("blood substitutes"): raison d'etre, chemistry and some physiology. Chem Rev 101:2797-2919.
25. Rudolph AS (1995) Encapsulation of hemoglobin in liposomes, in Blood substitutes: Physiological Basis of Efficacy (Intaglietta M ed) pp 90-104, Birkhauser, Boston.
26. Sakai H, Hamada K, Takeoka S, Nishide H, and Tsuchida E (1996) Physical properties of hemoglobin vesicles as red cell substitutes. Biotechnol Prog 12:119-125.
27. Sakai H, Takeoka S, Park SI, Kose T, Nishide H, Izumi Y, Yoshizu A, Kobayashi K, and Tsuchida E (1997) Surface modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity and blood flow during 90% exchange transfusion in anesthetized rats. Bioconjug Chem 8:23-30.
28. Sakai H, Tomiyama KI, Sou K, Takeoka S, and Tsuchida E (2000) Poly(ethylene glycol)-conjugation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state. Bioconjug Chem 11:425-432.
29. Semple SC, Chonn A, and Cullis PR (1998) Interactions of liposome and lipid-based carrier systems with blood proteins: relation to clearance behavior in vivo. Adv Drug Delivery Rev 32:3-17.
30. Shimada A, Matsuo S, Sadzuka Y, Miyagishima A, Nozawa Y, Hirota S, and Sonobe T (2000) Determination of incorporated amounts of poly(ethylene glycol)-derivatized lipids in liposomes for the physicochemical characterization of stealth liposomes. Int J Pharm 203:255-263.
31. Sou K, T. E., Takeoka S, and Tsuchida E (2000) Poly(ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles. Bioconjug Chem 11:372-379.
32. Squires JE (2002) Artificial blood. Science (Wash DC) 295:1002-1005.
33. Stewart JCM (1980) Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 104:10-14.
34. Szebeni J (1998) The interaction of liposomes with the complement system. Crit Rev Ther Drug Carrier Syst 15:57-88.
35. Takeoka S, Ohgushi T, Terase K, Ohmori T, and Tsuchida E (1996) Layer-controlled hemoglobin vesicles by interaction of hemoglobin with a phospholipid assembly. Langmuir 12:1755-1759.
36. Tomita S, Enoki Y, Santa M, Yoshida H, and Yasumitsu Y (1968) A simple spectrophotometric method for determination of met-hemoglobin in dilute solution. J Nara Med Assoc 19:1-6.
37. Torchilin VP and Papisov MI (1994) Why do polyethylene glycol-coated liposomes circulate so long? J Liposome Res 4:725-739.
38. Uster PS, Allen TM, Deniel BE, Mendez CJ, Newman MS, and Zhu GZ (1996) Insertion of ploy(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time. FEBS Lett 386:243-246.
39. Vandegriff KD, Malavalli A, Wooldridge J, Lohman J, and Winslow RM (2003) MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion 43:509-516.
40. Walde P and Ichikawa S (2001) Enzymes inside lipid vesicles: preparation, reactivity and applications. Biomol Eng 18:143-177.